Celon Pharma SA
Quick facts
Phase 2 pipeline
- CPL207280 · Diabetes
CPL207280 is a small molecule that targets the SGLT2 receptor. - CPL409116
- CPL500036 - high dose · Diabetes
CPL500036 is a small molecule that targets the SGLT2 receptor. - CPL500036 - low dose
CPL500036 is a low-dose drug with an unknown existing mechanism. - Esketamine DPI - high dose
- Esketamine DPI - low dose · Psychiatry / Neurology
Esketamine is an NMDA receptor antagonist that blocks glutamate signaling in the brain, with rapid-acting antidepressant effects. - Esketamine DPI - medium dose